James Constantine Padussis MD
Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Clinical Associate in the Department of Surgery, Duke University School of Medicine
Join to View Full Profile
987400 Nebraska Medical CtrOmaha, NE 68198
Phone+1 402-552-2000
Fax+1 402-552-2512
Dr. Padussis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Padussis is a surgical oncologist in Omaha, NE and is affiliated with Nebraska Medicine - Nebraska Medical Center. He received his medical degree from Boston University School of Medicine and has been in practice 12 years. He specializes in GI and HPB surgical oncology.
Education & Training
UPMC Medical EducationFellowship, Complex General Surgical Oncology, 2013 - 2015
Duke University HospitalFellowship, Advanced GI Minimally Invasive Surgery, 2012 - 2013- Duke University HospitalResidency, Surgery, 2005 - 2012
Boston University School of MedicineClass of 2005
Certifications & Licensure
NE State Medical License 2015 - 2026
NC State Medical License 2005 - 2015
PA State Medical License 2013 - 2015
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- Malignant tumors in tuberous sclerosis complex: a case report and review of the literature.Cassie Liu, Subodh M Lele, Martin H Goodenberger, Gwendolyn M Reiser, Andrew J Christiansen
BMC Medical Genomics. 2024-05-27 - 1 citationsGeographic variation in attitudes regarding management of locally advanced pancreatic cancer.Logan R McNeil, Alex B Blair, Robert W Krell, Chunmeng Zhang, Aslam Ejaz
Surgery Open Science. 2022-10-01 - 2 citationsSplenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients.Kathryn E Cole, Quan P Ly, Michael A Hollingsworth, Jesse L Cox, Kurt W Fisher
International Immunopharmacology. 2022-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
